Skip to main content

What you should know to reduce the risk of prostate cancer

·1 min

Prostate cancer is a significant concern, and early detection is essential. Prostate-specific antigen (PSA) testing is a vital tool for diagnosing and treating prostate cancer. Men should start PSA testing annually by the age of 50, or earlier if they have a family history, risk factors, or are Black. PSA testing, in combination with other diagnostic tests, helps identify prostate cancer in its early stages for better treatment outcomes. Regular PSA screenings are crucial, especially for high-risk individuals and during routine checkups. PSA testing has evolved with advancements in urine and blood tests and imaging technology, offering a more comprehensive picture of prostate health and cancer risk. Recent guidelines recommend initiating baseline PSA testing between ages 40 and 45 for Black men to address disparities in prostate cancer outcomes. Lowering the age for testing in this population could significantly reduce prostate cancer deaths. Men should prioritize proactive healthcare and open discussions with their healthcare providers to take charge of their prostate health.